 "madxuk2")
The Viennese medtech company MADx is continuing its expansion course and is taking over the distribution of its allergy diagnostics products in the UK under its own management with immediate effect. The company is thus further expanding its position in one of the fastest-growing healthcare markets in Europe.
ALEX, the world's most comprehensive molecular blood allergy test, was previously marketed by the manufacturer MADx via a distribution partner. Since the end of May 2025, MADx has been coordinating all sales and service activities itself and maintains a local team in the UK.